The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 480.00
Bid: 475.00
Ask: 485.00
Change: 7.50 (1.59%)
Spread: 10.00 (2.105%)
Open: 475.00
High: 480.00
Low: 472.50
Prev. Close: 472.50
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options and Director/PDMR Shareholding

25 May 2021 15:28

RNS Number : 7801Z
Warpaint London PLC
25 May 2021
 

25 May 2021

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

Grant of Options and Director/PDMR Shareholding

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces the grant of options ("Options") on 24 May 2021 over a total of 400,000 Ordinary Shares of 25p each in the Company ("Ordinary Shares") to two PDMRs under the Warpaint London PLC share option schemes.

The options are granted pursuant to the Company's annual review of share options to Neil Rodol, the Company's Chief Financial Officer and Matthew Goldstein, the Managing Director of the Group's subsidiary Retra Holdings Limited, both of whom are PDMRs, as part of their annual remuneration and incentivisation packages.

 

Position

Number of options granted

Total number of options held post grant

Options and grant date

Neil Rodol

Chief Financial Officer

250,000

662,258

105,262 (EMI)

306,996 (LTIP)

 24,590 (CSOP)

225,410 (non-qualifying)

29 June 2017

21 September 2018

24 May 2021

24 May 2021

Matthew Goldstein

Managing Director Retra

150,000

210,000

60,000 (CSOP)

150,000 (non-qualifying)

20 May 2020

24 May 2021

 

The Options are exercisable at a price of 122 pence per Ordinary Share, being the closing price the day prior to grant, from 24 May 2024 to 24 May 2031. The exercise of Options is not subject to the satisfaction of any performance criteria.

Following these grants the total number of options in issue over Ordinary Shares is 4,890,382 representing 6.37% of the Company's issued share capital of 76,752,355 Ordinary Shares.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Neil Rodol

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p

 

W7 ISIN: GB00BYMF3676

 

b)

Nature of the transaction

Grant of Option

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

122p

250,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

24 May 2021

f)

Place of the transaction

Outside a Trading Venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Matthew Goldstein

2

Reason for the notification

a)

Position/status

Managing Director Retra

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Warpaint London PLC

b)

LEI

213800EBJ2CN6KIDCO78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25p

 

W7 ISIN: GB00BYMF3676

 

b)

Nature of the transaction

Grant of Option

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

122p

150,000

 

d)

Aggregated information

- Aggregated volume

- Price

N/A - single transaction

e)

Date of the transaction

24 May 2021

f)

Place of the transaction

Outside a Trading Venue

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:

Warpaint London

Keith Sadler - Chairman of the Remuneration Committee

c/o IFC

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

 

N+1 Singer (Nominated Adviser & Joint Broker)

 

020 7496 3000

Shaun Dobson, Jen Boorer, Alex Bond - Corporate FinanceTom Salvesen - Corporate Broking

 

Shore Capital (Joint Broker)

020 7408 4090

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

IFC Advisory (Financial PR & IR)

 

020 3934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

 

Warpaint London plc

Warpaint is made up of two divisions.

The largest division sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using our other own brand names of Man'stuff, Body Collection, Vintage, Very Vegan, and Chit Chat.

The other division trades in close-out and excess inventory of branded cosmetics and fragrances from around the world.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDUSDDDGBU
Date   Source Headline
29th Apr 20247:37 amRNSHolding(s) in Company
24th Apr 20247:00 amRNSResults for the year ended 31 December 2023
9th Apr 20247:00 amRNSBlock listing Interim Return
9th Apr 20247:00 amRNSTrading Update and Notice of Results
26th Mar 20242:37 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSWard & Hagon Contract Renewal
12th Jan 20247:00 amRNSTrading Update
12th Dec 20237:00 amRNSAppointment of Non-Executive Directors
1st Dec 20233:37 pmRNSTotal Voting Rights
24th Nov 20237:00 amRNSGrant of Options
21st Nov 202311:23 amRNSPDMR Dealing
20th Nov 20231:24 pmRNSHolding(s) in Company
10th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSBlock Listing Interim Return
31st Oct 20237:00 amRNSTotal Voting Rights
13th Oct 20233:38 pmRNSHolding(s) in Company
4th Oct 20237:00 amRNSHolding(s) in Company
3rd Oct 20233:26 pmRNSHolding(s) in Company
3rd Oct 202312:25 pmRNSBlocklisting Application
28th Sep 20235:47 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
19th Sep 20233:51 pmRNSHolding(s) in Company
12th Sep 20237:00 amRNSNotice of Results
22nd Aug 202312:31 pmRNSHolding(s) in Company
27th Jul 20234:34 pmRNSHolding(s) in Company
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20231:40 pmRNSResult of AGM
28th Jun 20237:00 amRNSAGM Statement
15th Jun 20237:00 amRNSTrading Update
6th Jun 20237:00 amRNSPDMR Dealings
24th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
9th May 202311:28 amRNSHolding(s) in Company
2nd May 20234:31 pmRNSBlocklisting Application
26th Apr 20237:00 amRNSResults for the year ended 31 December 2022
24th Mar 20237:00 amRNSTrading Update and Notice of Results
14th Feb 202310:16 amRNSAIM Rule 17 Notification
11th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSResignation of Non-Executive Director
14th Oct 20227:00 amRNSRenewal of New Moorcroft House lease at Silsden
21st Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSChange of Adviser
8th Sep 20224:40 pmRNSSecond Price Monitoring Extn
8th Sep 20224:36 pmRNSPrice Monitoring Extension
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.